2019
DOI: 10.1016/j.repce.2019.03.011
|View full text |Cite
|
Sign up to set email alerts
|

Protocol-based follow-up program for heart failure patients: Impact on prognosis and quality of life

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

1
2
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 33 publications
1
2
0
Order By: Relevance
“…This study finding was in line with a study by (Bhosale et al, 2020) [8] who found that the majority of his study sample were males; mean age 55.8 years. Also, agree with (Agostinho et al, 2019) [2] who found that the majority of his study sample were males. Also, agree with (Rahim et al, 2018) [3] who found that Most subjects of both study and control groups were married.…”
Section: Discussionsupporting
confidence: 90%
“…This study finding was in line with a study by (Bhosale et al, 2020) [8] who found that the majority of his study sample were males; mean age 55.8 years. Also, agree with (Agostinho et al, 2019) [2] who found that the majority of his study sample were males. Also, agree with (Rahim et al, 2018) [3] who found that Most subjects of both study and control groups were married.…”
Section: Discussionsupporting
confidence: 90%
“…16 It is well recognised that the task of reducing hospital readmissions remains challenging in many high-income countries. 17,18 Further research should focus on safe discharge, 19 follow-up care for patients [20][21][22] and effective communication with primary care physicians. 23 The identification of eight conditions that carry greater mortality risk with identical AR episodes in this study is consistent with previous studies.…”
Section: Discussionmentioning
confidence: 99%
“…In a meta‐analysis of 36 randomized clinical trials published between 1993 and 2005, the authors found a marginal reduction of 3% in mortality 20 . Although HF patients on optimal medical therapy with mild or moderate symptoms do not typically benefit from long‐term follow‐up in a specialized HF clinic and are safely managed by their GP, 21 data are conversely difficult to interpret in unstable or severe patients and specialized follow‐up is associated with a greater reduction in mortality 22,23 . Indeed, worsening HF, defined by the deterioration of HF signs and symptoms requiring escalation of therapy, is a distinctive trajectory of patients with stage C HF, 24,25 i.e.…”
Section: Discussionmentioning
confidence: 99%